Generic Drug Makers Brace for FDA's 2026 Fee Changes
Published Date: 7/30/2025
Notice
Summary
Starting in fiscal year 2026, companies making generic drugs will see updated fees they need to pay to the FDA. These fees affect drug applications, manufacturing sites, and related programs, helping the FDA keep generic medicines safe and available. The new rates kick in soon, so businesses should get ready to budget for these changes.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in